lobbying_activities: 1725101

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1725101	e180299f-0baa-40b0-9cba-5b3746e29859	3T	XOMA CORPORATION (FKA XOMA (US) LLC)	400282354	XOMA CORPORATION (FKA XOMA (US) LLC)	2015	third_quarter	HCR	HR 6 "The 21st Century Cures Act," all provisions pertaining to patient access to treatments and orphan drug incentives. Senate draft legislation currently titled "Innovation for Healthier Americans," all provisions pertaining to orphan drug incentives.	HOUSE OF REPRESENTATIVES,SENATE		60000	0	1	2015-08-24T13:12:01.043000-04:00